Quick answers
- What is Acyclovir used for?
- The FDA-approved label (Zovirax, Bausch Health US, LLC, February 1, 2021) says: “ZOVIRAX Cream is a herpes simplex virus (HSV) deoxynucleoside analogue DNA polymerase inhibitor indicated for the treatment of recurrent herpes labialis (cold sores) in immunocompetent adults and adolescents 12 years of age and older. …” This page is not medical advice. Talk to your doctor or pharmacist before you start, stop or change any medicine.
- Does Acyclovir have a boxed warning?
- No. None of the 176 FDA labels we found for this medicine has a boxed warning.
- Is there a shortage of Acyclovir?
- No current shortage is listed by the FDA for the products of this medicine (FDA data from October 30, 2026).
- Has Acyclovir been recalled?
- FDA enforcement reports list 9 recalls of products of this medicine; the newest started December 28, 2022 (Class II). A recall usually concerns specific lots, not every product.
- Who makes Acyclovir?
- 66 companies list prescription products of Acyclovir in the FDA NDC Directory, including Bryant Ranch Prepack, Proficient Rx LP and NuCare Pharmaceuticals, Inc..
What Acyclovir is used for
Quoted from the “Indications and Usage” section of the FDA-approved label.
ZOVIRAX Cream is a herpes simplex virus (HSV) deoxynucleoside analogue DNA polymerase inhibitor indicated for the treatment of recurrent herpes labialis (cold sores) in immunocompetent adults and adolescents 12 years of age and older. …
— FDA label: Zovirax, Bausch Health US, LLC, effective February 1, 2021. Read the full label on DailyMed →
The FDA has 176 labels for products of this medicine (different makers and forms); uses can differ between them. Check the label that comes with your own medicine.
This page is not medical advice. Talk to your doctor or pharmacist before you start, stop or change any medicine.
Boxed warning
A boxed warning (“black box”) is the FDA’s strongest warning on a drug label, for serious or life-threatening risks.
The label quoted above has no boxed warning.
0 of 176 FDA labels for this medicine have a boxed warning.
Forms and how it is given
What pharmacies pay (NADAC)
The National Average Drug Acquisition Cost (NADAC) is the average price U.S. retail pharmacies paid to buy one unit of a medicine (one tablet, one mL or one gram), from a monthly survey of pharmacy invoices by the Centers for Medicare & Medicaid Services (CMS). State Medicaid programs use it to pay pharmacies.
This is not the price you pay. What you pay depends on your insurance (copay or coinsurance), your pharmacy and any discounts, and pharmacies also charge for filling a prescription. Ask your pharmacist or your health plan what your price will be.
| Strength and form | Generic or brand | Pharmacies pay |
|---|---|---|
| acyclovir 200 mg capsule | Generic | $0.0962 per capsule |
| acyclovir 200 mg/5 mL suspension | Generic | $0.0832 per mL |
| acyclovir 400 mg tablet | Generic | $0.0955 per tablet |
| acyclovir 5% cream | Generic | $8.85 per gram |
| acyclovir 5% ointment | Generic | $0.3639–$0.5283 per gram 15 packages, lowest to highest |
| acyclovir 800 mg tablet | Generic | $0.1965 per tablet |
NADAC list of November 4, 2026; these prices took effect on October 21, 2026. Shown only where a package’s NDC code matches the NADAC list exactly, and only for that exact strength and form: nothing is averaged across strengths. Strengths and forms not listed here have no NADAC price.
Source: NADAC (National Average Drug Acquisition Cost) 2026, data.medicaid.gov (CMS) →
Companies that list this medicine
Labelers in the FDA NDC Directory: the company named on the package (maker or distributor), with the number of prescription products.
- Bryant Ranch Prepack28 products
- Proficient Rx LP16 products
- NuCare Pharmaceuticals, Inc.15 products
- A-S Medication Solutions13 products
- Remedyrepack Inc.10 products
- Zydus Lifesciences Limited7 products
- Northwind Health Company, LLC4 products
- Preferred Pharmaceuticals Inc.4 products
- PD-Rx Pharmaceuticals, Inc.4 products
- Zydus Pharmaceuticals USA Inc.4 products
- Fresenius Kabi USA, LLC4 products
- Modavar Pharmaceuticals LLC3 products
- Atlantic Biologicals Corp.3 products
- Camber Pharmaceuticals, Inc.3 products
- Golden State Medical Supply, Inc.3 products
- Apotex Corp.3 products
- Yiling Pharmaceutical, Inc.3 products
- Viona Pharmaceuticals Inc3 products
- Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.3 products
- Chartwell RX, LLC3 products
- Carlsbad Technology, Inc.3 products
- Cadila Pharmaceuticals Limited3 products
- Aurobindo Pharma Limited3 products
- Major Pharmaceuticals2 products
- AvPAK2 products
- Redpharm Drug2 products
- Bionpharma Inc.2 products
- Sun Pharmaceutical Industries, Inc.2 products
- Amneal Pharmaceuticals LLC2 products
- Square Pharmaceuticals Limited2 products
- PharmPak, Inc.2 products
- Actavis Pharma, Inc.2 products
- Cardinal Health 107, LLC2 products
- Bausch Health US, LLC2 products
- Alembic Pharmaceuticals Inc.2 products
- Westminster Pharmaceuticals, LLC2 products
- American Health Packaging2 products
- Hikma Pharmaceuticals USA Inc.2 products
- Eugia US LLC2 products
- AuroMedics Pharma LLC2 products
- NorthStar Rx LLC1 product
- Avet Pharmaceuticals Inc.1 product
- Direct_Rx1 product
- Advagen Pharma Limited1 product
- Glenmark Pharmaceuticals Inc., USA1 product
- Sportpharm LLC1 product
- Macleods Pharmaceuticals Limited1 product
- Advanced Rx Pharmacy of Tennessee, LLC1 product
- Solco Healthcare US, LLC1 product
- Xiromed, LLC1 product
- Asclemed USA, Inc.1 product
- Coupler LLC1 product
- Chartwell Governmental & Specialty RX, LLC.1 product
- Quinn Pharmaceuticals1 product
- c1 product
- Teva Pharmaceuticals USA, Inc.1 product
- Aryeh Pharma Corp1 product
- Padagis Israel Pharmaceuticals Ltd1 product
- St. Mary's Medical Park Pharmacy1 product
- ANI Pharmaceuticals, Inc.1 product
- Florida Pharmaceutical Products, LLC1 product
- Torrent Pharmaceuticals Limited1 product
- Fera Pharmaceuticals, LLC1 product
- Novadoz Pharmaceuticals LLC1 product
- ProPharma Distribution1 product
- Slate Run Pharmaceuticals, LLC1 product
FDA approval history
- NDA: New Drug Application: how a new (usually brand-name) medicine is approved.
- ANDA: Abbreviated New Drug Application: how a generic version is approved.
| Application | Sponsor | Approved | Later changes approved |
|---|---|---|---|
| NDA018604 ZOVIRAX | Bausch | March 29, 1982 | 17, latest September 29, 2014 2014: Manufacturing (CMC) · 2002: Manufacturing (CMC) · 2001: Labeling |
| NDA021478 ZOVIRAX | Bausch | December 30, 2002 | 4, latest December 23, 2020 2020: Labeling · 2015: Manufacturing (CMC) · 2014: Labeling |
| NDA202408 AVACLYR | Fera Pharms LLC | March 29, 2019 | 1, latest July 16, 2021 2021: Labeling |
Generic approvals (44)
- ANDA074738Actavis Mid Atlantic · April 28, 1997
- ANDA074889Heritage · October 31, 1997
- ANDA074891Heritage · October 31, 1997
- ANDA074930Fresenius Kabi USA · May 13, 1998
- ANDA075211Aurobindo Pharma USA · September 28, 1998
- ANDA075090Regcon Holdings · January 26, 1999
- ANDA075382Carlsbad · April 30, 1999
- ANDA075677Apotex · September 28, 2005
- ANDA077309Apotex · September 29, 2005
- ANDA202459Pharmobedient · April 3, 2013
- ANDA203701Eugia Pharma · October 11, 2013
- ANDA203834Hetero Labs Ltd V · October 29, 2013
- ANDA202168Cadila Pharms Ltd · November 15, 2013
- ANDA201445Cadila Pharms Ltd · March 6, 2014
- ANDA204605Amneal Pharms · June 18, 2014
- ANDA204314Zydus Pharms · August 19, 2014
- ANDA205771Hikma · February 29, 2016
- ANDA204313Cadila · March 25, 2016
- ANDA205469Sun Pharma Canada · December 21, 2016
- ANDA205510Glenmark Speclt · July 31, 2017
- ANDA206261Carlsbad · August 16, 2017
- ANDA210401Pharmobedient · March 7, 2018
- ANDA209000Alembic · April 6, 2018
- ANDA206535Zydus Pharms · August 31, 2018
- ANDA209971Torrent · January 11, 2019
- ANDA208702Padagis Israel · February 4, 2019
- ANDA205974Zydus Lifesciences · March 15, 2019
- ANDA209366Adaptis · October 7, 2019
- ANDA201501Xiromed · January 29, 2020
- ANDA212718Chartwell Rx · April 23, 2020
- ANDA212252Novitium Pharma · July 10, 2020
- ANDA212173Pharmobedient · September 14, 2020
- ANDA208766Amneal · November 9, 2020
- ANDA212444Macleods Pharms · May 19, 2021
- ANDA212202Prinston Inc · November 15, 2021
- ANDA216331Aurobindo Pharma · March 31, 2022
- ANDA215669Hetero Labs Ltd III · July 1, 2022
- ANDA215724Rubicon Research · August 18, 2022
- ANDA206770Zydus Lifesciences · February 28, 2023
- ANDA217393Msn · March 9, 2023
Showing the 40 earliest of 44.
Shortage status
The FDA drug shortage list does not show these products.
Recalls
From FDA enforcement reports, matched by the product’s NDC code. A recall usually covers specific lots only: check the lot number on your package and ask your pharmacist. Do not stop a medicine on your own.
-
December 28, 2022 · Class II · Ongoing · D-0095-2023
Presence of Particulate Matter: Customer complaint of dark particles found inside the vial
Acyclovir Sodium Injection 1,000 mg per 20 mL* (50 mg/mL); Single Dose 20mL Vial, Rx only, Distributed by: AuroMedics Pharma LLC, 279 Princeton-Hightstown Rd, E. Windsor, NJ 08520; Made in India. NDC 55150-155-20 — Eugia US LLC
-
September 26, 2022 · Class II · Completed · D-0013-2023
Presence of Particulate Matter: Customer complaint for a dark red, brown and black particulate floating inside vial.
Acyclovir Sodium Injection, 500mg/10mL (50mg/mL), 10 mL Single Dose Vial, Rx only, Distributed by: AuroMedics Pharma LLC, 279 Princeton-Hightstown Rd., E. Windsor, NJ 08520; Made in India, NDC 55150-154-10. — AuroMedics Pharma LLC
-
April 21, 2021 · Class III · Terminated · D-0367-2021
Labeling: Incorrect or Missing Lot and/or Exp Date
Acyclovir Tablets, USP, 400 mg, 100 Tablets, Rx Only, Distributed by: Avet Pharmaceuticals Inc., East Brunswick, NJ 08816, NDC 23155-227-01. Packaged in 150 cc white HDPE bottle — Heritage Pharmaceuticals Inc
-
February 18, 2021 · Class I · Terminated · D-0315-2021
Crystallization: customer complaints for crystallization in finished product.
Acyclovir Sodium Injection 1000mg/20mL (50mg/mL) vial NDC 68382-049-01, For Intravenous Infusion Only MUST BE DILUTED PRIOR TO USE, packaged in 10 x 20mL Single-Dose Vials per pack NDC 68382-049-10, Rx only, Manufactured — Zydus Pharmaceuticals (USA) Inc
-
February 18, 2021 · Class I · Terminated · D-0316-2021
Crystallization: customer complaints for crystallization in finished product.
Acyclovir Sodium Injection 500mg/10mL (50mg/mL) vial NDC 68382-048-01, For Intravenous Infusion Only MUST BE DILUTED PRIOR TO USE, packaged in 10 x 10mL Single-Dose Vials per pack NDC 68382-048-10, Rx only, Manufactured — Zydus Pharmaceuticals (USA) Inc
-
April 25, 2019 · Class II · Terminated · D-1272-2019
Labeling; Label Mix-up; report received of one bottle labeled as Acyclovir Tablets USP 400 mg actually contained Carvedilol Tablets 6.25 mg
Acyclovir Tablets, USP, 400 mg, 100 count bottles, Rx Only Manufactured by: Cadila Healthcare Ltd., India Distributed by: Zydus Pharmaceuticals (USA) Inc. Pennington, NJ USA 08534 NDC 68382-791-01 — Zydus Pharmaceuticals USA Inc
-
February 9, 2018 · Class II · Terminated · D-0544-2018
Presence of Foreign Tablet/Capsule; cartons labeled to contain Acyclovir tablets may contain Torsemide tablets in some of the blister cavities.
Acyclovir Tablets, USP, 400 mg, 50 Tablets (5 x 10) unit dose blisters [NDC 50268-061-11] per carton [NDC 50268-061-15], Rx Only, Manufactured for: AvKARE, Inc., Pulaski, TN 38478 — Apace KY LLC
-
April 27, 2017 · Class III · Terminated · D-0897-2017
Presence of Foreign Substance: human hair melded into tablet.
Acyclovir Tablets, USP, 800 mg, 100-count bottle, Rx Only, Manufactured for: Camber Pharmaceuticals, Inc., Piscataway, NJ 08854, by Hetero Labs Limited, Unit V, Polepally, Jadcherla, Mahaboob Nagar - 509 301, India, NDC — Hetero USA Inc
-
July 17, 2013 · Class II · Terminated · D-017-2014
Presence of Particulate Matter: Product from lot KF2199, may contain tablets with pieces of nitrile rubber glove embedded within the tablets.
Acyclovir Tablets USP 800 mg ,(NDC 60505-5307-1), Rx only, Manufactured by Apotex Inc., Toronto, Ontario, Canada M9L 1T9, Manufactured for Apotex Corp.,Weston, Florida 33326. — Apotex Inc.
What do the recall classes mean?
Class I: The most serious type: there is a reasonable chance that using the product will cause serious health problems or death.
Class II: Using the product may cause temporary or medically reversible health problems, or the chance of serious problems is remote.
Class III: Using the product is not likely to cause health problems (for example a labeling or packaging issue).
Official identifiers
Sources
- FDA-approved label on DailyMed (National Library of Medicine) — Zovirax, Bausch Health US, LLC, effective February 1, 2021; via openFDA, FDA data exported October 30, 2026, retrieved October 31, 2026
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
- Drug shortages (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
openFDA data is provided by the FDA as is; it may be incomplete. Always rely on the label that comes with your medicine. FDA Enforcement Report search →